MYLUNG CONSORTIUM
LIVE

Serial Number

90508673

Owner

McKESSON CORPORATION

Attorney

Auma N. Reggy

First Use Date

Jan 26, 2021

Filing Date

Feb 3, 2021

Add to watchlist:

No watchlists yet
View on USPTO

MYLUNG CONSORTIUM Trademark

Serial Number: 90508673 • Registration: 6777452

MYLUNG CONSORTIUM is a trademark filed by McKESSON CORPORATION on February 3, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

McKESSON CORPORATION (419 trademarks)

CROCKER PLAZA
SAN FRANCISCO, CA 94104

Entity Type: 03

Trademark Details

Filing Date

February 3, 2021

Registration Date

July 5, 2022

First Use Anywhere

January 26, 2021

First Use in Commerce

January 26, 2021

Published for Opposition

April 19, 2022

Goods & Services

Downloadable electronic educational and professional publications, namely, newsletters, fact sheets, and brochures featuring information on research, testing, diagnosis, and treatment for lung cancer

Business management, business administration, and office function services in the nature of the facilitation and management of the collection, tracking, and maintenance of data relating to the testing, diagnosis, and treatment of lung cancer from medical providers, patients, medical researchers, and medical, biopharmaceutical, and biotechnology companies; business administration and office function services in the nature of the coordinating the collection, compilation, tracking, and maintenance of information and data relating to the testing, diagnosis, and treatment of lung cancer; Market intelligence services, namely, providing therapeutic insights and benchmarking information to stakeholders in the fields of medicine and healthcare; Promoting collaboration within the medical, research, scientific, and pharmaceutical, biopharmaceutical and biotechnology communities to achieve advances in lung cancer testing, diagnosis, and treatment; Promoting the exchange of information within the medical, research, scientific, and pharmaceutical, biopharmaceutical and biotechnology communities to achieve advances in lung cancer testing, diagnosis, and treatment; Providing information for the development of best practices for the testing, diagnosis, and treatment of lung cancer

Healthcare services, namely, collection of data and information on research, testing, diagnosis, and treatment of lung cancer for treatment and diagnostic purposes; Providing medical informational services for the purpose of raising awareness, and disseminating best practices for the testing, diagnosis, and treatment of lung cancer

Research services, namely, organizing collaborative research and development of protocols regarding the testing, diagnosis, and treatment of lung cancer for medical research purposes; Organizing collaboration in medical research and data collection around the testing, diagnosis, and treatment of lung cancer for medical research purposes; Organizing genomic, medical, biomedical and health care related research regarding lung cancer for medical research purposes; Providing medical research information in the field of lung cancer; Providing medical and scientific research information in the field of lung cancer

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 5, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 5, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 19, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 19, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 30, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 12, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 29, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 28, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 28, 2022 TROA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Oct 6, 2021 AAUA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 5, 2021 GNRN
NON-FINAL ACTION E-MAILED
Oct 5, 2021 GNRT
NON-FINAL ACTION WRITTEN
Oct 5, 2021 CNRT
USE AMENDMENT ACCEPTED
Oct 5, 2021 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Aug 16, 2021 AUPC
USE AMENDMENT FILED
Aug 16, 2021 IUAF
TEAS AMENDMENT OF USE RECEIVED
Aug 15, 2021 EAAU
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 12, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 19, 2021 GNRN
NON-FINAL ACTION E-MAILED
May 19, 2021 GNRT
NON-FINAL ACTION WRITTEN
May 19, 2021 CNRT
ASSIGNED TO EXAMINER
May 14, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 7, 2021 NWOS
NEW APPLICATION ENTERED
Feb 6, 2021 NWAP